Bridging the Gap: How Strategic Partnerships Are Transforming Breast Cancer Outcomes in Rural Ghana

Date: June 8, 2026 | Category: Health

Breast cancer remains the most prevalent malignancy affecting women worldwide. In Ghana, this clinical challenge is steeply compounded by systemic barriers: an estimated 50% to 70% of patients present with advanced disease (Stage III or IV), drastically limiting successful treatment outcomes and survival rates.

To counter this crisis, the Breast Cancer Unit at Holy Family Hospital (HFH) in Techiman was established in December 2023. Born from a strategic international partnership with Medical Support in Partnership (MSIP) based in Hamburg, Germany, this initiative is actively rewriting the narrative of oncology care in the Bono East Region.

The Pre-Intervention Landscape: A Region Unserved

Before December 2023, the infrastructure for breast health in Techiman and the broader Bono East Region faced severe structural and clinical challenges:

• Lack of Dedicated Infrastructure: There was no dedicated breast clinic, leading to fragmented and poorly coordinated management of breast conditions.
•  
• Prohibitive Financial Barriers: Essential diagnostics, including histological confirmation and advanced imaging like CT scans, were financially unattainable for most patients.
•  
• The Travel Burden: Chemotherapy services were completely non-existent in the region. Patients facing a life-threatening diagnosis were forced to endure a grueling four-hour commute to the nearest oncology center in Kumasi for routine treatments.
•  

Following a rigorous feasibility and assessment visit in October 2023 by MSIP’s leadership team—Dr. Ulf Buer, Prof. Susanna Hegewisch-Becker, and Dr. Kirsten Graubner—a definitive roadmap was drawn. Dr. Kingsley Bosompem was tasked with authoring the operational proposal and subsequently appointed to steer the new unit forward.

A Multi-Faceted Intervention Model

MSIP’s targeted intervention catalyzed a rapid upgrade of Holy Family Hospital’s clinical capabilities across three fundamental pillars:

1. Infrastructure and Cutting-Edge Equipment

• Chemotherapy Suite: Renovation of a dedicated space equipped with specialized electric chemotherapy chairs to maximize patient comfort during treatment infusions.
•  
• Laminar Flow Hood: Installation of advanced safety hoods to ensure the sterile and safe preparation of cytotoxic oncology medications.
•  
• Advanced Diagnostics: Introduction of a portable handheld ultrasound machine enabling real-time, image-guided core biopsies—the only service of its kind in the region.
•  
• Region-First Mammography: The acquisition of an ultramodern mammography machine—the first in the Bono East Region—now serves as a critical diagnostic hub for multiple regions across central Ghana.
•  

2. Clinical Capacity Building & International Exposure

• Domestic Specialized Training: Staff completed rigorous clinical rotations in chemotherapy administration at Ghana’s premier tertiary institutions, including Korle Bu Teaching Hospital (Accra) and Komfo Anokye Teaching Hospital (Kumasi).
•  
• Multidisciplinary Workshops: Pharmacists, palliative care nurses, and breast care nurses participated in specialized cross-functional workshops. On-site breast ultrasound training was personally led by Germany's Dr. Birgitta Beuer.
•  
• Hamburg Training Program: In April 2024, MSIP funded an intensive three-week clinical exposure program in Hamburg, Germany. This international observership trained local clinicians in advanced oncoplastic techniques, sentinel lymph node biopsies, breast-conserving surgeries, and complex mammography interpretation.
•  

Current Impact: Operational Metrics and Scope:

Today, the Breast Cancer Unit operates as a fully integrated, high-volume service hub, translating infrastructure into daily clinical outcomes across several core areas of operation:

Comprehensive Clinical Management: The dedicated Breast Clinic has scaled rapidly to meet local demand, actively managing a steady volume of 80 to 100 oncology patients every month.

Localized Chemotherapy Services: Operating seamlessly from Monday through Friday, the specialized Chemotherapy Unit regularly administers life-saving treatment regimens to 30 to 40 patients weekly, entirely removing the need for arduous regional travel.

Early Detection and Diagnostics: The facility provides daily walk-in breast screening alongside advanced diagnostics. This includes specialized ultrasound imaging and image-guided core biopsies for rapid, precise tissue confirmation.

Advanced Surgical Interventions: The surgical team executes full-scope clinical interventions on-site, including life-saving mastectomies and complex breast surgeries tailored to advanced presentations.

Community Advocacy and Outreach: To dismantle cultural stigmas, the unit leads localized advocacy initiatives, conducting regular educational campaigns and public health awareness broadcasts via regional radio programming.

Overcoming Persistent Challenges Through Innovation

While clinical milestones are significant, the unit continues to battle deep-seated structural and cultural roadblocks: financial constraints for low-income individuals, delayed clinical presentation driven by fear or cultural myths, limited access to high-cost targeted biological therapies (such as Trastuzumab), and infrastructure constraints relative to growing patient volume.

To systematically dismantle these hurdles, MSIP and Holy Family Hospital launched an ambitious one-year pilot project in October 2025 titled "Enhancing Breast Cancer Outcomes in Resource-Limited Communities through Partnership-Based Interventions."

Strategic Objectives of the Ongoing Pilot Project (Ending October 2026):

• Subsidized Care: Providing crucial financial lifelines for 100 to 150 newly diagnosed, low-income breast cancer patients to eliminate financial barriers to treatment access.
•  
• Decentralized Outreach: Training six public health nurses to execute aggressive community screening campaigns across all 13 districts, targeting at least 500 women per district.
•  
• Mobile Diagnostics: Deploying point-of-care ultrasound screening and immediate core biopsies directly into rural communities during outreach.
•  
• Multimedia Education: Broadcasting at least two educational radio programs per month alongside the production and wide dissemination of a dedicated 10-minute breast health documentary.
•  
• Patient Navigation & Data Systems: Introducing a structured Patient Navigation System to guide individuals seamlessly from initial diagnosis through one-year post-treatment. This is paired with a digitized data tracking system aimed at publishing clinical outcome data to contribute to global oncology research.
•  

Conclusion

The collaboration between Holy Family Hospital, Techiman, and Medical Support in Partnership (MSIP), Hamburg, serves as a powerful blueprint for international medical cooperation. By seamlessly blending infrastructure investments, targeted clinical training, financial patient support, and aggressive community-level advocacy, this partnership proves that high-quality, equity-driven oncology care is entirely achievable within resource-limited settings.

Through continued investment and local dedication, the unit is not only catching cancer earlier—it is giving women their lives back.

Booking and Inquiries

For any further questions regarding our services, public health educational outreach, or to schedule a professional clinical appointment for breast care screening, please connect directly with our dedicated customer care line:

Contact Hotline: 0202219048

Available Platforms: WhatsApp, Telegram, and Voice Call.